Circulating Forms of Urokinase-Type Plasminogen Activator Receptor in Plasma Can Predict Recurrence and Survival in Patients with Urothelial Carcinoma of the Bladder

SIMPLE SUMMARY: Bladder cancer is an aggressive disease and after operation many patients are at risk of recurrence and shortened survival. Specific proteins are known to be of importance in the development of cancers. One of these proteins is the urokinase-type plasminogen activator receptor (uPAR)...

Descripción completa

Detalles Bibliográficos
Autores principales: Dohn, Line H., Thind, Peter, Salling, Lisbeth, Lindberg, Henriette, Oersted, Sofie, Christensen, Ib J., Laerum, Ole D., Illemann, Martin, von der Maase, Hans, Høyer-Hansen, Gunilla, Pappot, Helle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8156453/
https://www.ncbi.nlm.nih.gov/pubmed/34069121
http://dx.doi.org/10.3390/cancers13102377

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8156453/
https://www.ncbi.nlm.nih.gov/pubmed/34069121
http://dx.doi.org/10.3390/cancers13102377

Ejemplares similares